RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Linagliptin Proves Safe and Effective as Add-on Therapy to Basal Insulin
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 16
SP 15
OP 16
DO 10.1177/155989771216006
UL http://mdc.sagepub.com/content/12/16/15.abstract
AB Linagliptin may be a treatment option in patients with type 2 diabetes mellitus (T2DM) taking basal insulin, especially in those prone to hypoglycemia and/or declining renal function, according to results from a 52-week, multicenter, randomized, placebo-controlled, Phase 3 clinical trial.